We have shown that intranodal administration of DRibbles combined with intraperitoneal anti-OX40 antibody induced antigen-specific T-cell activation and expansion and tumor regression in mice bearing established 4T1 tumors. This evidence concerns the gene TNFRSF4 and neoplasm.